Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.
about
HPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsComparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.Human papillomavirus infection and cervical dysplasia in female sex workers in Northeast China: an observational study.Identification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.Comparing the performance of six human papillomavirus tests in a screening populationClinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening.Significance of "Not Detected but Amplified" Results by Real-Time PCR Method for HPV DNA Detection.Understanding HPV tests and their appropriate applications.Improving Laboratory Efficiency by Automation of Preanalytic Processing of ThinPrep Specimens for Real-Time PCR High-Risk HPV Testing.The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias.Human papillomavirus test with cytology triage in organized screening for cervical cancer.Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.Comparison of digene hybrid capture 2, GeneMatrix PapilloScreen, and a PCR sequencing assay in detecting high-risk and probable high-risk oncogenic HPV genotypes in specimens from Korean women.Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework
P2860
Q26771420-945B1631-1F9E-4A28-9900-59875DDB6300Q30423690-D54C7B50-A8BB-4660-812F-734A817EB967Q35707053-FC7AF616-F86F-45E0-979B-8DFAFB76CC62Q35777190-59A395B3-E16B-4528-A765-B8742E4C5AE2Q36118559-E4D7810D-5095-4E7D-96B9-0E34060E263EQ36190228-CDD50F48-D7A8-42CD-BF15-2D4FD5CDCB9FQ36413963-F14A36F8-4DA3-4F97-8B29-73AAA5FF6A20Q36663594-D3F9E9E0-0D41-4180-AB2F-15E447AA9C86Q36971059-BC12648B-C5E9-46D5-83E9-BAC225B4C7A1Q37289143-C9CD369D-6E10-4112-B6B5-1B186517C3ECQ37554027-0B727456-EA90-4E4C-8CC8-A9D56E3FD862Q38133612-39B0C497-8B64-4436-92DA-1B9C90B5CC46Q38387930-D181DD86-BEC6-4B59-870F-9B446B21F743Q38606461-0F13203A-00BF-4D77-80C3-0567B7ECD04CQ38809544-E250C8F0-DEEB-41B0-91BF-4FF1CFB57868Q42209186-8621133A-5CCB-40DA-B991-64BC2D4EE468Q42235610-0CAFBCE0-FC8D-4AE2-BC5C-97C43F9F8A5AQ47097439-AFD015EF-2F69-48CE-B959-E62D3DA1574DQ58749448-9D5F6444-846E-45E1-9916-CD1948537F40
P2860
Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparison of clinical and ana ...... sed cervical cancer screening.
@ast
Comparison of clinical and ana ...... sed cervical cancer screening.
@en
type
label
Comparison of clinical and ana ...... sed cervical cancer screening.
@ast
Comparison of clinical and ana ...... sed cervical cancer screening.
@en
prefLabel
Comparison of clinical and ana ...... sed cervical cancer screening.
@ast
Comparison of clinical and ana ...... sed cervical cancer screening.
@en
P2093
P2860
P356
P1476
Comparison of clinical and ana ...... sed cervical cancer screening.
@en
P2093
Anja Ostrbenk
Eda Vrtacnik Bokal
Irena Klavs
Katja Seme
Mario Poljak
Nina Jancar
Peter Hillemanns
Veronika Ucakar
P2860
P304
P356
10.1128/JCM.00012-11
P407
P577
2011-03-23T00:00:00Z